Avivagen Inc.
VIVXF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.77K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7,769.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.09 |
| Beta | 0.35 |
| Outstanding Shares | 77,694,700 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.11 |
|---|---|
| PEG | 0.21 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
October 2, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$469,679
Consensus analyst estimateNext Earnings Call
Expected Date
December 30, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$469,548
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Avivagen Inc.
13 employees
CEO: G. F. Kym Anthony
Avivagen Inc. is a life sciences firm primarily engaged in creating and distributing specialized feed supplements for livestock. These products are designed to bolster animals' immune function and contribute to their enhanced growth and ...